A detailed history of Frg Family Wealth Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Frg Family Wealth Advisors LLC holds 44,515 shares of PFE stock, worth $1.11 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
44,515
Previous 44,350 0.37%
Holding current value
$1.11 Million
Previous $1.24 Million 3.87%
% of portfolio
0.24%
Previous 0.18%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$27.7 - $31.39 $4,570 - $5,179
165 Added 0.37%
44,515 $1.29 Million
Q2 2024

Aug 07, 2024

SELL
$25.26 - $29.6 $160,653 - $188,256
-6,360 Reduced 12.54%
44,350 $1.24 Million
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $195,987 - $225,056
-7,570 Reduced 12.99%
50,710 $1.41 Million
Q4 2023

Jan 09, 2024

SELL
$26.13 - $33.94 $282,778 - $367,298
-10,822 Reduced 15.66%
58,280 $1.68 Million
Q3 2023

Oct 11, 2023

SELL
$32.09 - $37.51 $21,981 - $25,694
-685 Reduced 0.98%
69,102 $2.29 Million
Q2 2023

Jul 13, 2023

SELL
$36.12 - $41.79 $177,746 - $205,648
-4,921 Reduced 6.59%
69,787 $2.56 Million
Q1 2023

Apr 18, 2023

SELL
$39.39 - $51.28 $90,793 - $118,200
-2,305 Reduced 2.99%
74,708 $3.05 Million
Q4 2022

Jan 25, 2023

SELL
$41.75 - $54.5 $132,347 - $172,765
-3,170 Reduced 3.95%
77,013 $0
Q3 2022

Oct 12, 2022

BUY
$43.76 - $53.42 $40,478 - $49,413
925 Added 1.17%
80,183 $3.51 Million
Q1 2022

May 06, 2022

BUY
$45.75 - $56.69 $4,575 - $5,669
100 Added 0.13%
79,258 $4.1 Million
Q4 2021

Feb 09, 2022

SELL
$41.32 - $61.25 $8,264 - $12,250
-200 Reduced 0.25%
79,158 $4.67 Million
Q3 2021

Mar 02, 2022

SELL
$39.25 - $50.42 $94,278 - $121,108
-2,402 Reduced 2.94%
79,358 $3.41 Million
Q2 2021

Mar 02, 2022

SELL
$35.91 - $40.68 $40,757 - $46,171
-1,135 Reduced 1.37%
81,760 $3.2 Million
Q1 2021

Mar 02, 2022

SELL
$33.49 - $37.77 $34,595 - $39,016
-1,033 Reduced 1.23%
82,895 $3 Million
Q4 2020

Mar 02, 2022

SELL
$33.47 - $42.56 $16,065 - $20,428
-480 Reduced 0.57%
83,928 $3.09 Million
Q3 2020

Mar 02, 2022

SELL
$31.75 - $37.25 $62,547 - $73,382
-1,970 Reduced 2.28%
84,408 $3.1 Million
Q2 2020

Mar 02, 2022

SELL
$30.12 - $36.54 $14,608 - $17,721
-485 Reduced 0.56%
86,378 $2.83 Million
Q1 2020

Mar 02, 2022

SELL
$27.03 - $38.62 $137,744 - $196,807
-5,096 Reduced 5.54%
86,863 $2.84 Million
Q4 2019

Mar 02, 2022

SELL
$32.92 - $37.36 $407,878 - $462,890
-12,390 Reduced 11.87%
91,959 $3.6 Million
Q3 2019

Mar 02, 2022

BUY
$32.49 - $42.13 $192,015 - $248,988
5,910 Added 6.0%
104,349 $3.75 Million
Q2 2019

Mar 02, 2022

BUY
$36.98 - $41.52 $43,451 - $48,786
1,175 Added 1.21%
98,439 $4.26 Million
Q1 2019

Mar 02, 2022

BUY
$37.5 - $41.2 $50,250 - $55,208
1,340 Added 1.4%
97,264 $4.13 Million
Q4 2018

Mar 02, 2022

BUY
$38.47 - $43.86 $148,686 - $169,518
3,865 Added 4.2%
95,924 $4.19 Million
Q3 2018

Mar 02, 2022

BUY
$34.47 - $41.81 $289,203 - $350,785
8,390 Added 10.03%
92,059 $4.06 Million
Q2 2018

Mar 02, 2022

BUY
$32.98 - $35.16 $217,008 - $231,352
6,580 Added 8.54%
83,669 $3.04 Million
Q1 2018

Mar 02, 2022

BUY
$31.91 - $37.02 $86,890 - $100,805
2,723 Added 3.66%
77,089 $2.74 Million
Q4 2017

Mar 02, 2022

BUY
$33.26 - $35.29 $22,417 - $23,785
674 Added 0.91%
74,366 $2.69 Million
Q3 2017

Mar 02, 2022

BUY
$31.0 - $34.15 $3,720 - $4,098
120 Added 0.16%
73,692 $2.63 Million
Q2 2017

Mar 02, 2022

BUY
N/A
1,131 Added 1.56%
73,572 $2.47 Million
Q1 2017

Mar 02, 2022

BUY
N/A
2,800 Added 4.02%
72,441 $2.49 Million
Q4 2016

Mar 02, 2022

BUY
N/A
1,887 Added 2.79%
69,641 $2.26 Million
Q3 2016

Mar 02, 2022

BUY
N/A
980 Added 1.47%
67,754 $2.3 Million
Q2 2016

Mar 02, 2022

BUY
N/A
2,779 Added 4.34%
66,774 $2.35 Million
Q1 2016

Mar 02, 2022

BUY
N/A
575 Added 0.91%
63,995 $1.92 Million
Q4 2015

Mar 02, 2022

BUY
N/A
63,420
63,420 $2.05 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $140B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Frg Family Wealth Advisors LLC Portfolio

Follow Frg Family Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frg Family Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frg Family Wealth Advisors LLC with notifications on news.